Cell and Gene Therapy for Oncology Market, By Therapy Type (Cell Therapy (Stem Cell Therapy, T-Cell Therapy, Mesenchymal Stem Cell (MSC) Therapy, and Others) and Gene Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, and Therapy Gene Transfer)), By Technology (Cell Therapy Technology (Autologous, Allogeneic, and Xenogeneic) and Gene Therapy Technology (Viral Vector-Based Gene Therapy and Non-Viral Vector-Based Gene Therapy)), By Indication (Breast Cancer, Lung Cancer, Prostate Cancer, Leukaemia and Lymphoma, and Others), By End User (Hospitals and Cancer Treatment Centers, Research and Academic Institutes, Biotechnology and Pharmaceutical Companies, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)
선택하다 귀사의 비즈니스 요구 사항에 맞는 라이센스 유형
US$ 2,200
이천이백 달러
단일 사용자 라이센스
( 전체 보고서 )
US$ 4,500
Four thousand five hundred dollars
자주 구매되는 상품
다중 사용자 라이센스
(전체 보고서)
US$ 7,000
Seven thousand dollars
기업 사용자 라이센스
(전체 보고서)
US$ 10000
Ten thousand dollars
Client Testimonials
Client Testimonials
우리의 고객